Answers are grounded in this paper and cite their sources.
( Birth . 2026;53(1):22–28. doi: 10.1111/birt.70027) Substance use disorders (SUDs) during pregnancy have become an increasingly significant public health concern, particularly in the context of the ongoing opioid epidemic. Rising rates of substance use among pregnant individuals have been associated with higher risks of maternal illness, mortality, and adverse neonatal outcomes. Despite the need for comprehensive health care services, many pregnant patients with SUDs encounter stigma and discrimination within health care settings. These negative experiences often discourage individuals from seeking prenatal care, addiction treatment, and other essential services. Fear of judgment, punitive responses, or involvement of child protective services can further prevent open communication with health care providers. As a result, reducing stigma among health care professionals has emerged as an important strategy for improving outcomes for pregnant individuals affected by SUDs.
No takes yet. Share an insight, caveat, or question.
Swenson et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: